Work

250P The impact of inter-cycle treatment delays on progression-free survival in early stage breast cancer

Year: 2023

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.447

Authors: L. Steventon, E. Kipps, K. Man, M.D. Forster, I. Wong, S. Shah, R. Miller, S. Nicum, O. Almossawi, P. Chambers

Institutions: University College London Hospitals NHS Foundation Trust, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, University College London, Great Ormond Street Hospital, Great Ormond Street Hospital for Children NHS Foundation Trust

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: AstraZeneca, National Institute for Health and Care Research, European Commission, Innovation and Technology Commission

Awards: Do Chemotherapy Dose-delays impact Patient treatment Outcomes?, G434337789

OpenAlex ID: W4387808952

FWCI: 0.291

Cites: 1

Cited by: 3

Related to: 10